The inactivation of STK11 gene or its protein product LKB1 is related to the cold tumor immune environment, which is accompanied by the decrease of infiltrating cytotoxic CD8+ T lymphocytes in both human tumors and genetically engineered mouse models (14). Here, CD8A is linked to neoplasm.